Aller au contenu principal
2023 conference-abstract

P069 The role of a specialist HIV pre-exposure prophylaxis pharmacist

0Citations signalées — pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Résumé fourni par la source

Introduction The efficacy of HIV Pre-Exposure Prophylaxis (PrEP) is well established, however success largely depends on reach, access and medication adherence. This review describes the expanding role of a pharmacist within a sexual and reproductive health (SRH) clinic including the benefits of improved quality of care and access to PrEP. Method Data was collected on successful service improvements implemented by a specialist HIV PrEP pharmacist. Results Since being in post from July 2022 the pharmacist alongside members of the MDT has led on the following service improvements:- • Implementation of a streamlined all-day nurse led clinic for routine PrEP through patient group directive sign offs and education and training. This has led to an increase in uptake of PrEP by 30%. • Establishing a weekly virtual complex PrEP MDT clinic to review medical complexities such as side effects and renal impairment. This has allowed us to provide options and nephrology referrals for patients who cannot take NHS PrEP. Over 500 patients which is over 20% of our cohort has been reviewed over a 6-month period. • Creation of an online appointment system for PrEP appointments. • Implementation of a weekly Pharmacist PrEP clinic for training new staff and reviewing complex patients (up to 5 patients/week). • Strategic planning for novel deliveries of PrEP to increase capacity and access for marginalised communities (e.g. via medication lockers and remote pathways). Discussion Pharmacists are experts in medication, adherence counselling, adverse effects and monitoring which are critical to clinically successful and safe PrEP usage. PrEP service leadership by a pharmacist skilled in HIV/SRH with an understanding of contracts and supply chain has proven to be beneficial. Together with other clinicians, pharmacists should be directly involved in driving PrEP service development to improve access, reach and lead complex MDTs.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
P069 The role of a specialist HIV pre-exposure prophylaxis pharmacist
Date Crossref
01/06/2023
Éditeur
BMJ Publishing Group Ltd
Type
proceedings-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskHealthcare Systems and Practices

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.